跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
NMPA
/
Aflibercept Intravitreous Injection
Approved
生物制品
Aflibercept Intravitreous Injection
BAYER AG
🇨🇳 National Medical Products Administration
Approval Date
Apr 10, 2023
Approval ID
1yQCMsedAqu
Company
BAYER AG
Type
生物制品
Approval Details
Approval Id
1yQCMsedAqu
Approval Number
国药准字SJ20180010
Generic Name
阿柏西普眼内注射溶液
Generic Name En
Aflibercept Intravitreous Injection
Trade Name
艾力雅
Drug Type
生物制品
Dosage Form
注射剂
Strength
40mg/mL, 每瓶可抽取体积为0.1mL, 相当于4mg阿柏西普
Reg Date
2023-04-10
Expired Date
2028-04-09
Company Name
BAYER AG
Production Company Name
Vetter Pharma-Fertigung GmbH & Co. KG
Company Detail Path
/organization/bayer-ag
Production Company Detail Path
/organization/vetter-pharma-fertigung-gmbh-and-co-kg
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Apr 10, 2023
Approval ID
1yQCMsedAqu
Type
生物制品
Back to NMPA Approvals
艾力雅 - NMPA Drug Approval Details